Director/PDMR Shareholding

RNS Number : 7570I

Reckitt Benckiser Group PLC

02 September 2016

 

2 September 2016

RECKITT BENCKISER GROUP PLC

("RB" or the "Company")

 DIRECTOR/PDMR SHAREHOLDING

Notification of a transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

The Company announces that, following vesting and release of a restricted share award over 10,283 shares on 1 September 2016 to Darrell Stein, SVP Information Services, a Person Discharging Managerial Responsibility, 4,843 shares were sold at £73.52 per share to cover Mr Stein's tax liabilities and sale costs.  Mr Stein retained the remaining Shares.   

Following this notification, Mr Stein's shareholding is 11,781 Shares, representing 0.00167% of the Company's issued share capital. Treasury shares have not been taken into account when calculating this percentage.

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Darrell Stein
2	Reason for the notification
a)	Position/status	PDMR - SVP Information Systems
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Reckitt Benckiser Group plc
b)	LEI	5493003JFSMOJG48V108
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 10p each in Reckitt Benckiser Group plc ("Shares") GB00B24CGK77
b)	Nature of the transaction	Release of vested restricted share award over 10,283 Shares at nil consideration (1) and sale of sufficient shares to meet tax liabilities and sale costs (2).
c)	Price(s) and volume(s)	Price(s) Volume(s) 1. Nil-consideration 10,283 2. £73.52 4,843
d)	Aggregated information -       Aggregated volume -       Price	N/A
e)	Date of the transaction	All transactions took place on 2016-09-01.
f)	Place of the transaction	London Stock Exchange, Main Market - XLON

For further Information:
Christine Logan

Company Secretary
Tel [phone]

About RB:

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately 37,000 people worldwide.

Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.

RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea. 

For more information visit www.rb.com 

*RB is the trading name of the Reckitt Benckiser group of companies

 

END

 

 

DSHBLGDCSXGBGLB